Whittier Trust’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $6.82K | Hold |
124
| – | – | ﹤0.01% | 1295 |
|
2025
Q1 | $8.77K | Sell |
124
-175
| -59% | -$12.4K | ﹤0.01% | 1233 |
|
2024
Q4 | $19.7K | Sell |
299
-78
| -21% | -$5.13K | ﹤0.01% | 1114 |
|
2024
Q3 | $26.5K | Hold |
377
| – | – | ﹤0.01% | 1041 |
|
2024
Q2 | $31K | Sell |
377
-1,700
| -82% | -$140K | ﹤0.01% | 999 |
|
2024
Q1 | $181K | Sell |
2,077
-86
| -4% | -$7.51K | ﹤0.01% | 667 |
|
2023
Q4 | $209K | Hold |
2,163
| – | – | ﹤0.01% | 636 |
|
2023
Q3 | $191K | Hold |
2,163
| – | – | ﹤0.01% | 631 |
|
2023
Q2 | $187K | Hold |
2,163
| – | – | ﹤0.01% | 643 |
|
2023
Q1 | $210K | Hold |
2,163
| – | – | ﹤0.01% | 644 |
|
2022
Q4 | $224K | Hold |
2,163
| – | – | ﹤0.01% | 621 |
|
2022
Q3 | $183K | Buy |
2,163
+1,700
| +367% | +$144K | ﹤0.01% | 650 |
|
2022
Q2 | $38K | Hold |
463
| – | – | ﹤0.01% | 1015 |
|
2022
Q1 | $36K | Hold |
463
| – | – | ﹤0.01% | 1048 |
|
2021
Q4 | $41K | Hold |
463
| – | – | ﹤0.01% | 1020 |
|
2021
Q3 | $36K | Hold |
463
| – | – | ﹤0.01% | 1004 |
|
2021
Q2 | $39K | Hold |
463
| – | – | ﹤0.01% | 1010 |
|
2021
Q1 | $35K | Hold |
463
| – | – | ﹤0.01% | 1012 |
|
2020
Q4 | $41K | Hold |
463
| – | – | ﹤0.01% | 891 |
|
2020
Q3 | $35K | Buy |
463
+210
| +83% | +$15.9K | ﹤0.01% | 900 |
|
2020
Q2 | $31K | Hold |
253
| – | – | ﹤0.01% | 883 |
|
2020
Q1 | $21K | Hold |
253
| – | – | ﹤0.01% | 970 |
|
2019
Q4 | $21K | Hold |
253
| – | – | ﹤0.01% | 1014 |
|
2019
Q3 | $17K | Buy |
253
+73
| +41% | +$4.91K | ﹤0.01% | 1047 |
|
2019
Q2 | $15K | Hold |
180
| – | – | ﹤0.01% | 1005 |
|
2019
Q1 | $16K | Hold |
180
| – | – | ﹤0.01% | 987 |
|
2018
Q4 | $15K | Hold |
180
| – | – | ﹤0.01% | 1012 |
|
2018
Q3 | $17K | Hold |
180
| – | – | ﹤0.01% | 968 |
|
2018
Q2 | $17K | Hold |
180
| – | – | ﹤0.01% | 948 |
|
2018
Q1 | $15K | Hold |
180
| – | – | ﹤0.01% | 982 |
|
2017
Q4 | $16K | Hold |
180
| – | – | ﹤0.01% | 959 |
|
2017
Q3 | $17K | Hold |
180
| – | – | ﹤0.01% | 928 |
|
2017
Q2 | $16K | Hold |
180
| – | – | ﹤0.01% | 917 |
|
2017
Q1 | $16K | Buy |
180
+5
| +3% | +$444 | ﹤0.01% | 927 |
|
2016
Q4 | $14K | Hold |
175
| – | – | ﹤0.01% | 924 |
|
2016
Q3 | $16K | Hold |
175
| – | – | ﹤0.01% | 899 |
|
2016
Q2 | $14K | Hold |
175
| – | – | ﹤0.01% | 932 |
|
2016
Q1 | $14K | Hold |
175
| – | – | ﹤0.01% | 920 |
|
2015
Q4 | $18K | Hold |
175
| – | – | ﹤0.01% | 879 |
|
2015
Q3 | $18K | Hold |
175
| – | – | ﹤0.01% | 866 |
|
2015
Q2 | $24K | Hold |
175
| – | – | ﹤0.01% | 865 |
|
2015
Q1 | $22K | Hold |
175
| – | – | ﹤0.01% | 854 |
|
2014
Q4 | $16K | Hold |
175
| – | – | ﹤0.01% | 811 |
|
2014
Q3 | $13K | Hold |
175
| – | – | ﹤0.01% | 827 |
|
2014
Q2 | $11K | Hold |
175
| – | – | ﹤0.01% | 850 |
|
2014
Q1 | $12K | Hold |
175
| – | – | ﹤0.01% | 862 |
|
2013
Q4 | $12K | Hold |
175
| – | – | ﹤0.01% | 868 |
|
2013
Q3 | $13K | Hold |
175
| – | – | ﹤0.01% | 860 |
|
2013
Q2 | $10K | Buy |
+175
| New | +$10K | ﹤0.01% | 882 |
|